Jiangsu Jibeier Pharmaceutical Co Ltd Total Liabilities
Jiangsu Jibeier Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has total liabilities worth CN¥222.75 Million CNY (≈ $32.60 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Jiangsu Jibeier Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Total liabilities of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. This chart illustrates how Jiangsu Jibeier Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Jiangsu Jibeier Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangsu Jibeier Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ridgepost Capital, Inc
NYSE:RPC
|
USA | $506.42 Million |
|
Shandong Link Science and Technology Co Ltd
SHE:001207
|
China | CN¥1.02 Billion |
|
Salfacorp
SN:SALFACORP
|
Chile | CL$1.12 Trillion |
|
Tortoise Energy Infrastructure Closed Fund
NYSE:TYG
|
USA | $304.75 Million |
|
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC
|
Turkey | TL13.28 Billion |
|
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658
|
China | CN¥1.86 Billion |
|
Hangzhou Jiebai Group Co Ltd
SHG:600814
|
China | CN¥3.54 Billion |
|
Hiecise Precision Equipment Co Ltd
SHE:300809
|
China | CN¥570.43 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Jiangsu Jibeier Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 688566 total assets.
Liquidity & Leverage Metrics
Jiangsu Jibeier Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Jiangsu Jibeier Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Jibeier Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
The table below shows the annual total liabilities of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥267.47 Million ≈ $39.14 Million |
-2.27% |
| 2024-12-31 | CN¥273.68 Million ≈ $40.05 Million |
-8.55% |
| 2023-12-31 | CN¥299.25 Million ≈ $43.79 Million |
+10.73% |
| 2022-12-31 | CN¥270.24 Million ≈ $39.55 Million |
+28.45% |
| 2021-12-31 | CN¥210.40 Million ≈ $30.79 Million |
+23.10% |
| 2020-12-31 | CN¥170.92 Million ≈ $25.01 Million |
+36.56% |
| 2019-12-31 | CN¥125.16 Million ≈ $18.31 Million |
+4.02% |
| 2018-12-31 | CN¥120.32 Million ≈ $17.61 Million |
+38.43% |
| 2017-12-31 | CN¥86.92 Million ≈ $12.72 Million |
-26.96% |
| 2016-12-31 | CN¥118.99 Million ≈ $17.41 Million |
-- |
About Jiangsu Jibeier Pharmaceutical Co Ltd
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing… Read more